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Abstract: Agents that alter the dynamics of hemostasis form an important 
part in management of conditions such as atherosclerosis, cerebrovascular 
disease, and bleeding diatheses. In this study, we explored the effects of 
heparin and tranexamic acid on the efficiency of blood coagulation. Using 
optical  tweezers,  we  evaluated  the  pN-range  micro-interaction  between 
coagulating  red  blood  cells  (RBCs)  by  measuring  the  minimum  power 
required to trap them. By observing the mobility of RBCs and the intensity of 
cellular interactions, we found that the coagulation process can be separated 
into three phases. The effects of heparin and tranexamic acid were examined 
by observing variations in cellular interaction during the coagulation phases. 
Heparin attenuated the interaction between RBCs and prolonged the first 
phase whereas the samples containing tranexamic acid bypassed the first two 
phases and immediately proceeded to the final one. 
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1. Introduction 
One of the functions of blood is the transportation of metabolic substrates in the human body. 
Hemostasis is critical to survival particularly to control hemorrhage and ensures that circulating 
blood is maintained within the intravascular space [1]. Optical tweezers are powerful tools used 
for the micro-manipulation of biological molecules and are created using laser beam technology 
[2]. In this study, the interaction between coagulating red blood cells (RBCs) was determined 
by measuring the optical power required to trap them. By observing the degree of interaction 
and mobility of coagulating RBCs, we were also able to demonstrate that the coagulation 
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that can inhibit the activity of platelets or the coagulation process, whereas antihemorrhagic 
drugs include agents that cause platelet activation or inhibit fibrinolysis and clot dissolution [3]. 
We found that with the addition of an  antithrombotic reagent, blood  samples exhibited a 
delayed first phase and a prolonged coagulation phase. The addition of an antifibrinolytic 
reagent caused samples to proceed through the first two phases immediately to the third phase 
and complete the whole coagulation process. 
2. Materials and methods 
2.1 Estimation of optical trapping force 
To estimate the trapping force of optical tweezers, a laser spot of power P was applied to a 
sample particle, as shown in Fig. 1(a). The sample stage was dragged to the right where a 
viscous drag force FD was applied to the particle, as shown in Fig. 1(b). At the same time, a 
transverse trapping force FL was applied to the particle by a fixed laser spot (shown by a circle 
with a cross) in the opposite direction [4]. 
 
Fig. 1. Estimation of trapping force on a particle by dragging the sample stage. 
When the particle is displaced from the equilibrium,  the trapping force increases to a 
power-dependent maximum value called escape force, and then begins to decrease to zero [5]. 
When the viscous drag force FD was smaller than the escape force, the particle was confined by 
optical tweezers; when FD was equal to or slightly larger than the escape force, the particle 
began to be dragged out of the spot and escape the trap. The viscous drag force FD applied to the 
dragged particle was determined by Stokes’ Law [6]: 
  D 6π, F Rv      (1) 
where η denotes the viscosity coefficient of fluid, R denotes the radius of particle, and v the 
dragging speed of the stage. As the trapping force FL was balanced with the viscous drag force 
FD at equilibrium, Eq. (1) was used to evaluate the trapping force FL of the optical tweezers. 
According to the theory of optical tweezers [7]: 
  L /c, F nP     (2) 
where n denotes the index of incident media, P is the power of source, and c the vacuum speed 
of light. Varying the optical power P applied to the particle, we measured the trapping force FL 
and derived the curve of FL(P) versus P. By using the relation curve, we determined the 
microscopic trapping force FL directly for a given laser power P. 
2.2 The interaction between red blood cells in coagulation 
During the process of coagulation, an RBC is attracted by a coagulative interaction FB from the 
right coagulated group, as shown in Fig. 2. In order to stop the cell from moving to this group, 
sufficient power was applied to a spot to make the trapping force FL greater than the coagulative 
interaction FB. With the power reduced to a critical value P, the cell began to escape the trap and 
was attracted to the right, as illustrated in Fig. 2. At this point, FB was balanced with FL. Using 
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required to trap the coagulating RBC. 
 
Fig. 2. Evaluation of the interaction between RBCs by the trapping force of optical tweezers. 
2.3 Apparatus and materials 
A 1064 nm IR laser, an optical microscope and a 100 × oil lens were utilized to establish the 
optical tweezers system, as depicted in Fig. 3. A motorized X-Y stage was equipped to the 
system to induce viscous drag force, by which the trapping forces of the optical tweezers were 
determined. In the below coagulation experiments, samples were prepared by diluting 20 μl of 
blood in 1 ml of normal saline. Control samples were prepared without the addition of drug 
substances. In the other samples, 20 μl of 100 IU heparin and 20 μl of 3% tranexamic acid were 
added. 
 
Fig. 3. A schematic diagram of the optical tweezers where the red dashed rectangle illustrates the 
microscope. 
3. Results and discussion 
3.1 The evaluation of coagulating interaction 
As stated previously, dragging experiments were performed to determine the trapping force FL 
of the optical tweezers. The dependence of trapping force FL on varying laser power P is 
summarized in Table 1 and Fig. 4, which are used accordingly to derive the interaction between 
coagulating RBCs. 
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power P, “Speed” indicates the dragging speed v, and “Force” the trapping force of the 
optical tweezers. The trapping force is derived from Eq. (1) with the viscosity coefficient η 
of 0.0055 N-sec/m
2 [8] and the cell radius R of ~4.5 μm 
Power (mW)  Speed (μm/s)  Force (pN) 
30  0.69  0.32 
60  1.05  0.47 
90  3.06  1.43 
120  3.31  1.55 
150  3.88  1.81 
180  4.38  2.04 
210  5.00  2.33 
240  6.25  2.92 
270  7.38  3.44 
300  7.50  3.50 
330  8.13  3.79 
360  8.25  3.85 
380  8.38  3.91 
 
Fig. 4. Trapping force as a function of optical power, where “Power” denotes the laser power and 
“Force” the induced trapping force. Based on the data listed in Table 1, the blue dashed curve 
with 10% error bars is plotted here along with its red linear trend line. 
The process used to evaluate coagulating interactions is illustrated in Fig. 5. In Fig. 5(a), the 
coagulating RBCs 1 and 3 were attracted to the blood group on the left. By applying higher laser 
power, RBC 1 was trapped and stopped moving to the left, as shown in Fig. 5(b). However, 
when the power was reduced to ~130 mW, cell 1 was released and was attracted to the blood 
group again, as shown in Fig. 5(c) and Fig. 5(d). According to the data shown in Table 1, the 
coagulating force FB on RBC 1 was estimated to be ~1.64 pN. 
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Fig. 5. (Media 1) The process to evaluate the interaction between coagulating RBCs. 
3.2 The phases of blood coagulation 
The blood samples were prepared on microscope slides and situated on the stage of optical 
tweezers for coagulation experiments, as shown in Fig. 6. Coagulation was initiated in blood 
solution located outside the edge of the coverslip, which exerted outward attractive forces on 
the remainder of the sample. As the coverslip and slide were bonded by a two-sided adhesive 
tape which served as a spacer as thick as 50~100 μm, the attracted RBCs could move outwards 
free of effects from the substrates. Based on the mobility of the RBCs and the strength of 
intercellular interactions, we observed three distinct coagulation phases. In the first phase, the 
RBCs vibrated around their equilibrium positions. In the second phase, individual RBCs began 
to  shift  outwards  to  the  coagulated  region,  while  the  final  phase  featured  intense  group 
migration until the entire process was complete. 
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Fig. 6. The preparation of blood samples for coagulation experiments. 
For blood samples with no additives, RBCs were randomly distributed inside or outside the 
coverslip at the beginning. After the coagulated region was formed, RBCs located on the inside 
exhibited attraction and began to shift individually and slowly outwards. After the process 
proceeded for roughly five minutes, extensive cell migration commenced, marking the third 
phase. Cellular interaction versus coagulation time is summarized in Fig. 7(a). In the second 
phase, interaction ranged from ~1.0 pN at beginning and increased to ~3.9 pN at around five 
minutes. In the third phase, the interaction was so intense that the 380 mW source power was 
insufficient to trap the rapidly-moving RBCs. 
#133392 - $15.00 USD Received 16 Aug 2010; revised 26 Sep 2010; accepted 19 Oct 2010; published 22 Oct 2010
(C) 2010 OSA 1 November 2010 / Vol. 1,  No. 4 / BIOMEDICAL OPTICS EXPRESS  1222 
Fig. 7. (Media 2) (a) The variation of interaction between coagulating cells in normal blood 
samples. Note that subject 1 is a male of age 15, subject 2 is a male of age 22, subject 3 is a 
female of age 23, subject 4 is a female of age 33, and subject 5 is a male of age 39. (b) Variations 
in cellular interactions in blood samples treated with  heparin [9]. (c) Variations in cellular 
interactions in blood samples treated with tranexamic acid [10]. (d) Variations in averaged cell 
interactions in three types of blood samples. The control samples are denoted as “Normal”; the 
ones  treated  with  heparin  or  tranexamic  acid  are  denoted  as  “Heparin”  or  “Tranexamic”, 
respectively. 
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attenuated  the  inter-cellular  interaction  and  prolonged  the  coagulation  time.  Figure  7(b) 
illustrates the time variation of cellular interaction in the blood samples. The addition of heparin 
extended the first phase by keeping the interaction at ~1.5 pN for four minutes. At around seven 
minutes, the samples proceeded to the second phase with a corresponding increase in force. The 
interaction increased to 3.9 pN at ten minutes at which point the third phase commenced. The 
addition of heparin postponed coagulation for about five minutes. 
The  sample  containing  tranexamic  acid  immediately  entered  the  third  phase  at  the 
beginning. The fast and intense group migration allowed the overall coagulation process to be 
completed within two minutes. Figure 7(c) shows the variation in cellular interactions of the 
samples. As illustrated, we found that the interaction increased towards and stabilized at 3.9 pN 
till the end of the process. 
Time variations in the micro-interaction of the three samples are summarized in Fig. 7(d). 
The control sample entered the second phase at the beginning and the intensity of cellular 
interactions increased with time until the third phase began at five minutes. Heparin containing 
samples  exhibited  a  prolonged  first  phase  without  group  migration  or  net  coagulation. 
Contrastingly, samples containing tranexamic acid proceeded immediately to the third phase 
and completed the coagulation within two minutes. 
4. Conclusion 
In this study, we used optical tweezers to evaluate the microscopic interactions between RBCs 
during coagulation. The pN-scale interaction was derived by the optical power required to trap 
the cells. Variations in the intensity of cellular interactions over time allowed us to describe the 
coagulation process as three distinct phases. We also confirmed the effects of heparin and 
tranexamic acid on coagulation by examining the cellular interactions throughout each phase. 
The results of this study provide an objective assessment of the effects of medications on the 
efficiency of coagulation. 
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